Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study - Wikidata - awgldk - TriplyDB

Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study

Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study

http://www.wikidata.org/entity/Q24603670

about

Incidence of Augmentation in Primary Restless Legs Syndrome Patients May Not Be That High: Evidence From A Systematic Review and Meta-Analysis Strategies for the treatment of restless legs syndrome Treatment of restless legs syndrome The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guidel Gabapentin enacarbil: in patients with restless legs syndrome.Role of gabapentin enacarbil XR in restless legs syndrome Review of the treatment of restless legs syndrome: focus on gabapentin enacarbil.Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose?Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.Possible sites of therapeutic action in restless legs syndrome: focus on dopamine and α2δ ligands.Gabapentin enacarbil for the treatment of restless legs syndrome (RLS).European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society.Restless legs syndrome: a review of diagnosis and management in primary care.Gabapentin enacarbil: pharmacotherapy of restless legs syndrome Pharmacological Management of Restless Legs Syndrome and Periodic Limb Movement Disorder in Children.Gabapentin Enacarbil: A Review in Restless Legs Syndrome.The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.Efficacy and Tolerability of Gabapentin in Adults with Sleep Disturbance in Medical Illness: A Systematic Review and Meta-analysis.New uses for older drugs: the tales of aspirin, thalidomide, and gabapentin Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil.Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.Treatment of dyssomnias and parasomnias in childhood.Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.

P2860

Q26772047-5A0AB8F8-51FA-4FE2-ABD4-1F26D57413CB Q26829911-2B8FDA55-8685-4AC3-9FDC-C43FEFF306EC Q27024585-46769359-5B96-4235-BA4F-F90B20C978E8 Q27024854-BB01DFED-2C27-48DD-860E-42204129C29B Q34313624-9563D8E7-AB2F-471B-A08E-0E597D6450AE Q35940214-C1F1D5BD-AAF5-48E7-B347-F48BC310F358 Q36748697-D3E54419-84E8-49A8-AE30-F78D5AC32DBF Q37577779-E7700A29-3BCC-4376-B88A-D9D099C11845 Q37678223-DF8C5E63-E5D9-49A3-B67F-0D406B1FBD3C Q37895053-96EEDF73-0D9A-46E0-A037-A61BA371D627 Q37955269-2142BD7F-4D9F-4648-94B4-0B151D1B4453 Q38039480-FF461F17-1F5A-4504-8988-F212B20A7A58 Q38113094-17FA8E92-4444-483D-9AF6-9F0761556FA4 Q38122149-112DFFCB-E732-4271-B3E8-7E3D287AFFC3 Q38612985-210E8164-5CC1-4482-8CDD-1852DDF67952 Q38825763-42BCA7ED-FEC6-432E-8218-536B34BC2894 Q39838178-E6FA463B-69B7-493F-9464-4C96B856C8E4 Q41015870-900C09D4-DD63-4765-8EB6-883CCEA9E245 Q42766204-AEF78EEF-F978-4CEC-A9FB-428C1D785F78 Q46153517-EBB01B9F-340B-4054-BB3B-2ED6103E68A9 Q47980634-9D66CF22-A660-4EBF-B777-99566DA88F40 Q48221262-02815C0C-49EF-47FA-B7B1-F98E220F12CF Q53126274-4142BEC7-4E68-4025-818E-3C195A617B3C

P2860

Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study

http://www.wikidata.org/entity/Q24603670

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Long-term maintenance treatmen ...... a randomized controlled study

@ast

Long-term maintenance treatmen ...... a randomized controlled study

@en

Long-term maintenance treatmen ...... a randomized controlled study

@nl

type

label

Long-term maintenance treatmen ...... a randomized controlled study

@ast

Long-term maintenance treatmen ...... a randomized controlled study

@en

Long-term maintenance treatmen ...... a randomized controlled study

@nl

prefLabel

Long-term maintenance treatmen ...... a randomized controlled study

@ast

Long-term maintenance treatmen ...... a randomized controlled study

@en

Long-term maintenance treatmen ...... a randomized controlled study

@nl

P1433

Q24603670-E712FFCD-0B03-476F-B21A-38D0199A3711

P1476

Q24603670-0DE13859-7AF8-4E84-A061-9C4A43FD7FB5

P2093

Q24603670-197433F8-29F3-4903-AEEE-21452EC6E617

Q24603670-1D6D52C9-2C00-4F98-9DAF-1A056FE8A8D5

Q24603670-91E5EFEA-1AB9-432C-99D8-86D9DF5B2623

Q24603670-A4B25B51-D5BD-4828-BCE3-7643CE7B599B

Q24603670-C1D134FB-686E-4B91-89D4-43213B8C4E38

P2860

Q24603670-23E4711A-6E1E-4835-9D0A-F2C511017476

Q24603670-2D8ADB14-5217-40C0-B215-D9FF1BA07B44

Q24603670-32FF6170-0EF0-4196-9DD1-082C9E1F87AC

Q24603670-44387CE5-1BB2-4B0E-9955-14E9AF476EF4

Q24603670-4955F005-4A68-4315-AA93-7A7081027320

Q24603670-4BF04BB6-49E1-4F41-B888-7800D94D70A5

Q24603670-4DE4D7C9-64E4-4274-ACC3-65C8345405B1

Q24603670-5244D23D-8D9B-49D3-A414-978F1976D269

Q24603670-57D55A33-1708-44F9-B303-D0208BF84261

Q24603670-6D4EBB6D-7CC3-4895-96F9-2947AB8FB9D7

P304

Q24603670-708D6CA4-820F-4E06-A719-A7DDE9CC779E

P31

Q24603670-901253CB-8E13-4763-B257-7D6F7C65B23C

P356

Q24603670-A6DACB45-3121-4AFD-B313-A18A7CC23C8E

P407

Q24603670-D553611C-3437-4CAB-98F3-9BBBD0DF6B63

P433

Q24603670-46C5EAEB-0E7F-443F-9302-EBD360E5B0F7

P478

Q24603670-917CD28E-1C16-4463-9529-882246F1F6A7

P577

Q24603670-63CBDEF7-9B32-4779-8639-F59EC36A4D7F

P5875

Q24603670-B39A68B1-31C1-40D7-9DF0-499B8C2B07CF

P698

Q24603670-47B330C9-D8B3-41C6-9CB7-2AD57E915FD7

P921

Q24603670-B89C490A-2535-4AF1-A2D0-68BED7EEBF09

Q24603670-BBCEFAB5-F3EA-4FCE-9AEF-71F772C78B7C

Q24603670-FD871378-9B63-4F1D-8C64-DA941B6B3A08

P932

Q24603670-96DAD9A7-7160-43A2-85D4-FDB691EE1FFF

P356

P1433

Mayo Clinic Proceedings

P1476

Long-term maintenance treatmen ...... a randomized controlled study

@en

P2093

Clete A Kushida

http://www.w3.org/2001/XMLSchema#string

Michel A Cramer Bornemann

http://www.w3.org/2001/XMLSchema#string

Pierre V Trân

http://www.w3.org/2001/XMLSchema#string

Richard K Bogan

http://www.w3.org/2001/XMLSchema#string

Ronald W Barrett

http://www.w3.org/2001/XMLSchema#string

P2860

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters.

XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkey

Restless legs syndrome prevalence and impact: REST general population study.

Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.

Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.

Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin.

Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries

A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.

P304

512-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4065/MCP.2009.0700

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44638933

http://www.w3.org/2001/XMLSchema#string

P698

20511481

http://www.w3.org/2001/XMLSchema#string

P921

gabapentin enacarbil

restless legs syndrome

P932

2878254

http://www.w3.org/2001/XMLSchema#string